Literature DB >> 23954113

Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients.

D M Guerrero1, J C Becker, E C Eckstein, S Kundrapu, A Deshpande, A K Sethi, C J Donskey.   

Abstract

Asymptomatic carriage of Clostridium difficile is common in hospitals, but the risk for transmission by carriers is unclear. In this point prevalence culture survey of asymptomatic hospitalized patients, 18 of 149 (12%) were carriers of toxigenic C. difficile. By comparison with C. difficile infection (CDI) patients, the prevalence of skin and/or environmental contamination was significantly lower in asymptomatic carriers (3/18, 17% versus 5/6, 83%; P = 0.007), but carriers outnumbered CDI patients in the hospital by a factor of 3 to 1. These data suggest that asymptomatic carriers have the potential to contribute to C. difficile transmission in hospitals. Published by Elsevier Ltd.

Entities:  

Keywords:  Asymptomatic carriers; Clostridium difficile; Transmission

Mesh:

Year:  2013        PMID: 23954113     DOI: 10.1016/j.jhin.2013.07.002

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  31 in total

Review 1.  Laboratory diagnosis of bacterial gastroenteritis.

Authors:  Romney M Humphries; Andrea J Linscott
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

Review 2.  Hospital Infection Control: Clostridioides difficile.

Authors:  Nicholas A Turner; Deverick J Anderson
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

3.  Clostridium difficile in the Long-Term Care Facility: Prevention and Management.

Authors:  Robin L P Jump; Curtis J Donskey
Journal:  Curr Geriatr Rep       Date:  2015-03

4.  Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.

Authors:  Elisabeth M Terveer; Monique J T Crobach; Ingrid M J G Sanders; Margreet C Vos; Cees M Verduin; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2016-11-16       Impact factor: 5.948

5.  Modeling the potential impact of administering vaccines against Clostridioides difficile infection to individuals in healthcare facilities.

Authors:  Damon J A Toth; Lindsay T Keegan; Matthew H Samore; Karim Khader; Justin J O'Hagan; Holly Yu; Alvaro Quintana; David L Swerdlow
Journal:  Vaccine       Date:  2020-07-21       Impact factor: 3.641

6.  Utility of a commercial PCR assay and a clinical prediction rule for detection of toxigenic Clostridium difficile in asymptomatic carriers.

Authors:  Curtis J Donskey; Venkata C K Sunkesula; Annette L Jencson; Nimalie D Stone; Carolyn V Gould; L Clifford McDonald; Matthew Samore; Jeanmarie Mayer; Susan Pacheco; Susan Sambol; Laurica Petrella; Deborah Terry; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

Review 7.  Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis.

Authors:  Ioannis M Zacharioudakis; Fainareti N Zervou; Elina Eleftheria Pliakos; Panayiotis D Ziakas; Eleftherios Mylonakis
Journal:  Am J Gastroenterol       Date:  2015-03-03       Impact factor: 10.864

Review 8.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

9.  Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.

Authors:  Matthew Ziegler; Daniel Landsburg; David Pegues; Warren Bilker; Cheryl Gilmar; Colleen Kucharczuk; Theresa Gorman; Kristen Bink; Amy Moore; Rebecca Fitzpatrick; Edward A Stadtmauer; Patricia Mangan; Kelly Kraus; Jennifer H Han
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-24       Impact factor: 5.742

10.  The Importance of Colonization with Clostridium difficile on Infection and Transmission.

Authors:  Daniel J Morgan; Surbhi Leekha; Lindsay Croft; Carey-Ann D Burnham; J Kristie Johnson; Lisa Pineles; Anthony D Harris; Erik R Dubberke
Journal:  Curr Infect Dis Rep       Date:  2015-09       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.